Stay updated on Pembrolizumab Combos in mCRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.

Latest updates to the Pembrolizumab Combos in mCRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no user-facing content or behavior has changed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. No visible changes to the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision from v3.4.0 to v3.4.1 is shown; no impact on the study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page shows a new revision label v3.3.4 added and the previous label v3.3.3 removed, reflecting a minor metadata update with no change to study data, eligibility criteria, or trial arms. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedLocations section reorganized into a centralized listing of sites across the United States (California, Colorado, Connecticut, Florida, Illinois, New Jersey, Pennsylvania, Texas, Washington) and Canada (Alberta, Ontario, Quebec), replacing earlier per-location headings. Revision tag updated from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check110 days agoChange DetectedPublications note text updated: added a sentence clarifying that publications are provided voluntarily and relate to study results, and the previous wording was removed; the revision/version label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combos in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.